"Apollo Endosurgery, Inc. is a medical device company focused on less invasive therapies for the treatment of obesity, a condition facing over 600 million people globally, as well as other gastrointestinal disorders. Our device based therapies are an alternative to invasive surgical procedures, thus lowering complication rates and reducing total healthcare costs. Apollo’s products are offered in over 70 countries today."

During the past decade, Apollo Endosurgery conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Apollo Endosurgery" are "Morbid Obesity" (1 trials), "Obesity" (1 trials) and "Obesity, Morbid" (1 trials). Many other conditions were trialed in "Apollo Endosurgery" in a lesser frequency.

Most popular intervention types in "Apollo Endosurgery" are "Device" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Behavioral modification" (1 trials), "BioEnterics® Intragastric Balloon" (1 trials), "LAP-BAND AP Adjustable Gastric Banding System" (1 trials) and "LAP-BAND System" (1 trials). Other intervention names were less common.

The vast majority of trials in "Apollo Endosurgery" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Apollo Endosurgery". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Apollo Endosurgery, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Apollo Endosurgery, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".